TMFUltraLong

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the health care sector, but also has a penchant for mining, retail, and automotive stocks, as well as personal finance and macroeconomic topics of interest.

TMFUltraLong’s Activity

Yesterday

NL

Article

TMFUltraLong published an article 12:00 AM

The 1 Factor That Could Boost Apple Inc. 20% to $155

Forget a $750 billion valuation -- this research firm believes one primary factor could be the key to launching Apple to $155 per share or a $900 billion valuation.

NL

Article

TMFUltraLong published an article 12:00 AM

Here's How Google Inc. Could Get to $670

Could Google stock have 16% upside? According to this Wall Street firm, it could, thanks to a a bountiful number of catalysts.

NL

Article

TMFUltraLong published an article 12:00 AM

Why Netflix, Inc. Could Plummet 39% -- and That's Being "Generous"

One Wall Street analyst believes Netflix shares are grossly overvalued, and this comes after raising his company's price target on it by more than 10%.

NL

Article

TMFUltraLong published an article 12:00 AM

Why GW Pharmaceuticals PLC Smoked 11% Higher in February

Marijuana stocks are all the rage, and cannabinoid-based drug developer GW Pharmaceuticals continues to enjoy the changing perception of marijuana among the public and investors. Find out what sent its shares higher by double-digits in February and [more]

NL

Article

TMFUltraLong published an article 12:00 AM

Why Citigroup Inc. Shares Banked 12% Gains in February

Global banking giant Citigroup vaults 12% higher in February following a quartet of positive news events. Can its shares keep up the momentum?

NL

Article

TMFUltraLong published an article 12:00 AM

This Wall Street Firm Just Took a Swipe at American Express Company

As if things couldn't get any worse for American Express, a Wall Street firm just cut its rating and its price target on the credit and processing giant. Will AmEx ever be "buy-worthy" again?

Tue Mar 3

NL

Article

TMFUltraLong published an article 12:00 AM

Why Mastercard, Inc. Charged 10% Higher in February

MasterCard shares rallied by double-digits in February thanks to two under-the-radar events. Find out what has investors so excited.

NL

Article

TMFUltraLong published an article 12:00 AM

Why Exelixis, Inc. Shares Skyrocketed 57% in February

Exelixis shares soared in February as shareholders await two key catalysts.

NL

Article

TMFUltraLong published an article 12:00 AM

Sarepta Therapeutics Inc.'s Price Target Was Slashed By 27% -- Time to Panic?

It's been a rough 12 months for Sarepta Therapeutics, and it got even rougher on Monday following a substantial price target cut from a Wall Street firm. Find out whether this price cut is justified and what investors should consider doing next.

Mon Mar 2

NL

Article

TMFUltraLong published an article 12:00 AM

Why Wall Street Played Whack-A-Mole With 3D Systems Corporation's Valuation

3D printing specialist 3D Systems gets its price target slashed by three Wall Street firms. Find out what set off this wave of pessimism and discover whether or not it's warranted.

NL

Article

TMFUltraLong published an article 12:00 AM

Is This 20% Cut in Bank of America Corp.'s Price Target Justified?

One Wall Street company took it to the nation's second-largest U.S. bank by assets on Friday, downgrading its rating and slashing its price target. Find out what set it off -- and whether investors should be concerned.

Fri Feb 27

NL

Article

TMFUltraLong published an article 12:00 AM

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That

This year will likely mark Pfizer's fifth consecutive year of revenue declines. But a quick solution to its growth concerns could lie within one (or more) of these three proposed fixes.

NL

Article

TMFUltraLong published an article 12:00 AM

The Startlingly Large Obamacare Consequenece That's About to Hit Millions of Taxpayers

Despite enrolling far more people than expected, an unintended consequence of Obamacare is that it's wreaking havoc on the pocketbooks of millions of taxpayers.

NL

Article

TMFUltraLong published an article 12:00 AM

Does Domino's Pizza, Inc. Have the Right Ingredients to Rise Another 15%?

Following its fourth-quarter earnings results earlier this week, Domino's Pizza catches a price target hike from research firm Argus. Do Domino's shares have the right ingredients to tack on an additional 15% in gains?

NL

Article

TMFUltraLong published an article 12:00 AM

Does This Downgrade of Chesapeake Energy Corporation Make Sense?

Following its fourth-quarter earnings results, investment bank UBS downgrades Chesapeake Energy and slashes its price target. Is this move merited, or is pessimism surrounding Chesapeake already baked in?

Thu Feb 26

NL

Article

TMFUltraLong published an article 12:00 AM

Did Researchers Just Discover a Functional Cure for Duchenne Muscular Dystrophy?

Duchenne muscular dystrophy has no cure, and it often kills its victims by their mid-20s. However, a new international study lends hope that a functional cure to this disease could be in the offing.

NL

Article

TMFUltraLong published an article 12:00 AM

Can Celgene Corporation Climb Another 26%?

Analysts at this research firm believe Celgene has substantial upside left in its shares. But do the numbers add up?

NL

Article

TMFUltraLong published an article 12:00 AM

Here's How Apple Inc. Stock Could Get to $150

According to research firm Stifel Nicolaus, Apple stock could have plenty of upside still left. Find out what catalysts the firm believes could send Apple shares to $150.

NL

Article

TMFUltraLong published an article 12:00 AM

Following 2 Upgrades and 2 Price Target Hikes, Is First Solar, Inc. a Buy?

First Solar shines brightly after announcing a recent joint venture with SunPower and receiving some love from Wall Street in the process. The real question left is whether or not you should still buy its shares after the latest rally.

NL

Article

TMFUltraLong published an article 12:00 AM

Could This Analyst's Dire Forecast for Transocean Ltd. Come True?

Investment banking firm UBS cuts its price target and slashes its EPS estimates for offshore drilling contractor Transocean. Are things really this dire for the deepwater drilling giant?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.90
Player Rank 75 out of 75068
Score 9533.77
Score Change Today -427.53
Accuracy 87.73%
Active Picks 105
Total Picks 506
Best Pick FAZ (+314.70)
Worst Pick PCYC (-7812.87)
Average Score per Pick 18.99
Charms Earned 16
Highest Rated Favorite TMFBabo
Go to TMFUltraLong’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 3
Recs Received 11
People who have rec'd these posts 11
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board CAPS Feedback
Very First Post Tickering....Just a heads up... (10/14/2010)
Percentage of Posts Rec'd 100.00 %
Show TMFUltraLong’s 10 Latest Posts